Glen Burkhardt - 19 Nov 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
VP, Human Resources
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Nov 2021
Net transactions value
-$2,076
Form type
4
Filing time
23 Nov 2021, 17:50:15 UTC
Previous filing
24 May 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $11,590 +5,766 $2.01* 5,766 19 Nov 2021 Direct F1
transaction PHASQ Common Stock Sale $13,665 -5,766 -100% $2.37* 0 19 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.